Literature DB >> 9932884

Microelectrode recording during posteroventral pallidotomy: impact on target selection and complications.

R L Alterman1, D Sterio, A Beric, P J Kelly.   

Abstract

OBJECTIVE: To assess the practical usefulness of single-cell microelectrode recording (MER) when performing posteroventral pallidotomy.
METHODS: A retrospective comparison of the initial, magnetic resonance imaging-derived coordinates of the pallidotomy target to the final, MER-refined lesion coordinates in 132 consecutive pallidotomies was conducted. The time required to perform the procedure and the surgical complications are reported.
RESULTS: MER led to targeting changes in 98% of the cases. In 12%, the MER-refined target was more than 4 mm from the original, image-guided site, which is a targeting error that could adversely affect outcome. Although all components of targeting were affected by MER, laterality and depth were impacted most. The ventral border of the globus pallidus pars interna was located within 1 mm of the magnetic resonance imaging-selected target in only 40% of the cases. On average, only 2.2 MER trajectories were required to perform pallidotomy. During the last 3 years of our study, 85% of the procedures were performed with one or two trajectories. The mean operating time of the operations performed during the last 3 years was 2 hours and 12 minutes. The incidence of intracerebral hemorrhage in our series (1.5%) was no higher than that reported for other large series of stereotactic procedures. No patient suffered an optic tract injury.
CONCLUSION: MER provides important targeting information for performing pallidotomy. In particular, the micrometric delineation of the ventral border of the globus pallidus pars interna permits safe lesioning of the posteroventral region of the globus pallidus pars interna with little risk of visual field deficit. These data can be obtained efficiently and without increased surgical risk.

Entities:  

Mesh:

Year:  1999        PMID: 9932884     DOI: 10.1097/00006123-199902000-00036

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Multicenter study report: electrophysiological monitoring procedures for subthalamic deep brain stimulation surgery in Parkinson's disease.

Authors:  Sara Marceglia; Simona Mrakic-Sposta; Giorgio Tommasi; Luigi Bartolomei; Camillo Foresti; Franco Valzania; Salvatore Galati; Alessandro Stefani; Filippo Tamma; Alberto Priori
Journal:  Neurol Sci       Date:  2010-04-23       Impact factor: 3.307

2.  Selection of optimal programming contacts based on local field potential recordings from subthalamic nucleus in patients with Parkinson's disease.

Authors:  Nuri Firat Ince; Akshay Gupte; Thomas Wichmann; James Ashe; Thomas Henry; Margaret Bebler; Lynn Eberly; Aviva Abosch
Journal:  Neurosurgery       Date:  2010-08       Impact factor: 4.654

3.  Mismatch between electrophysiologically defined and ventriculography based theoretical targets for posteroventral pallidotomy in Parkinson's disease.

Authors:  M Merello; A Cammarota; D Cerquetti; R C Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

Review 4.  Motor cortex stimulation for pain and movement disorders.

Authors:  Jeffrey E Arle; Jay L Shils
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

5.  Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi.

Authors:  Lo J Bour; M Fiorella Contarino; Elisabeth M J Foncke; Rob M A de Bie; Pepijn van den Munckhof; Johannes D Speelman; P Richard Schuurman
Journal:  Acta Neurochir (Wien)       Date:  2010-10-15       Impact factor: 2.216

6.  Safety and long-term efficacy of ventro-oral thalamotomy for focal hand dystonia: A retrospective study of 171 patients.

Authors:  Shiro Horisawa; Taku Ochiai; Shinichi Goto; Takeshi Nakajima; Nobuhiko Takeda; Atsushi Fukui; Tomoko Hanada; Takakazu Kawamata; Takaomi Taira
Journal:  Neurology       Date:  2018-12-26       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.